Key Prerequisites for the Correct Management of Intermediate-risk Prostate Cancer (European Urology Oncology)

In this issue of European Urology Oncology, Preisser et al [1] present a comprehensive review of the stratification and management of patients with intermediate-risk prostate cancer (PCa). While it is clear that many important questions still remain unanswered, we should see the glass as being half full. In fact, the authors clearly show that intermediate-risk PCa patients can be effectively and safely approached with a variety of therapeutic modalities including active surveillance, watchful waiting, partial gland ablation, radical prostatectomy, and radiation therapy in its various technical variations.